glp-1 in development GLP-1R Agonists for Weight Loss GLP-1 Receptor Agonist Services for

Triazolotriazine, triazole, thiomorpholine, and pyrimidinedione analogs 3.1.2

GLP-1 has been tested as a regulator of anxiety behavior and both GLP-1 and exendin-4 (administered ip , into the lateral ventricle or intra-dorsal raphe) induced anxiety-like behavior, which was measured in the black and white box, elevated plus maze and open field tests in Spraque-Dawley rats [86]

This indication can be covered under Medicare Part D and potentially certain Florida Blue commercial plans with prior authorization distinct from the excluded weight-loss benefit

Tras su secrecin, circula en dos formas activas principales GLP-1 (736) y GLP-1 (737), con una vida media corta debido a su rpida degradacin por la enzima DPP-IV (1)